Evome Medical Technologies, Inc. Shareholders' Equity
Evome Medical Technologies, Inc. had Shareholders' Equity of CAD 4.00 million as of 2023-12-31, per its 10-K filed 2024-04-16.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2024-04-16
- 2023-12-31: Stockholders' Equity Attributable to Parent 4.00M CAD.
- 2023-09-30: Stockholders' Equity Attributable to Parent 19.39M CAD.
- 2023-06-30: Stockholders' Equity Attributable to Parent 15.82M CAD.
- 2023-03-31: Stockholders' Equity Attributable to Parent 14.01M CAD.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2023-12-31 | 4.00M CAD 10-K · filed 2024-04-16 | |
| 2023-09-30 | 19.39M CAD 10-Q · filed 2023-11-14 | |
| 2023-06-30 | 15.82M CAD 10-Q · filed 2023-11-14 | |
| 2023-03-31 | 14.01M CAD 10-Q · filed 2023-08-14 | |
| 2022-12-31 | 15.33M CAD 10-K · filed 2024-04-16 | |
| 2022-11-30 | 16.15M CAD 10-Q · filed 2023-01-17 | |
| 2022-09-30 | 15.59M CAD 10-Q · filed 2023-11-14 | |
| 2022-08-31 | 16.06M CAD 10-Q · filed 2023-01-17 | |
| 2022-06-30 | 24.41M CAD 10-Q · filed 2023-11-14 | |
| 2022-05-31 | 24.69M CAD 10-Q · filed 2022-10-17 | 24.69M CAD 10-Q · filed 2022-07-15 |
| 2022-03-31 | 13.01M CAD 10-Q · filed 2023-08-14 | |
| 2022-02-28 | 13.15M CAD 10-K · filed 2024-04-16 | |
| 2021-12-31 | 8.76M CAD 10-Q · filed 2023-11-14 | |
| 2021-11-30 | 10.08M CAD 10-Q · filed 2023-01-17 | |
| 2021-08-31 | 11.18M CAD 10-Q · filed 2023-01-17 | |
| 2021-05-31 | 11.47M CAD 10-Q · filed 2022-10-17 | |
| 2021-02-28 | 6.64M CAD 10-KT · filed 2023-04-03 | |
| 2020-11-30 | 8.50M CAD 10-Q · filed 2022-01-14 | |
| 2020-08-31 | 8.83M CAD 10-Q · filed 2022-01-14 | |
| 2020-05-31 | 9.55M CAD 10-Q · filed 2021-10-15 | |
| 2020-02-29 | 9.50M CAD 10-K · filed 2022-05-31 |